These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 19481136)

  • 1. Enhanced in vivo motility of human umbilical cord blood hematopoietic stem/progenitor cells introduced via intra-bone marrow injection into xenotransplanted NOD/SCID mouse.
    Gao J; Li Y; Lu S; Wang M; Yang Z; Yan X; Zheng Y
    Exp Hematol; 2009 Aug; 37(8):990-7. PubMed ID: 19481136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The observation of engraftment of human umbilical cord blood-derived hematopoietic stem/progenitor cells in xenotransplanted NOD/SCID mouse model by intra-bone marrow injection].
    Gao JT; Lu SH; Li YH; Yang Z; Xu J; Zheng YZ
    Zhonghua Xue Ye Xue Za Zhi; 2008 Jun; 29(6):361-5. PubMed ID: 19031735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cell factor improves SCID-repopulating activity of human umbilical cord blood-derived hematopoietic stem/progenitor cells in xenotransplanted NOD/SCID mouse model.
    Zheng Y; Sun A; Han ZC
    Bone Marrow Transplant; 2005 Jan; 35(2):137-42. PubMed ID: 15543197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced engraftment of umbilical cord blood-derived stem cells in NOD/SCID mice by cotransplantation of a second unrelated cord blood unit.
    Nauta AJ; Kruisselbrink AB; Lurvink E; Mulder A; Claas FH; Noort WA; Willemze R; Fibbe WE
    Exp Hematol; 2005 Oct; 33(10):1249-56. PubMed ID: 16219548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Differential study on the in vivo homing potential of human hematopoietic stem/progenitor cells from different sources in xenotransplanted NOD/SCID mouse model].
    Yang Z; Lu SH; Li YH; Liu B; Wang HJ; Jia HR; Zheng YZ
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jun; 28(6):391-5. PubMed ID: 17939405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra-bone marrow transplantation facilitates pauci-clonal human hematopoietic repopulation of NOD/SCID/beta2m(-/-) mice.
    Levac K; Menendez P; Bhatia M
    Exp Hematol; 2005 Nov; 33(11):1417-26. PubMed ID: 16263425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SCID-repopulating activity of human umbilical cord blood-derived hematopoietic stem and/or progenitor cells in a nonobese diabetic/Shi-SCID mice serial xenotransplantation model and immune cell activities in vitro: a comparative study of the filter method and the hydroxyethyl starch method.
    Yasutake M; Zheng Y; Inoue-Nagamura T; Akagawa E; Tokushima Y; Terashima S; Takahashi TA
    Transfusion; 2005 Dec; 45(12):1899-908. PubMed ID: 16371042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Umbilical cord blood xenografts in immunodeficient mice reveal that T cells enhance hematopoietic engraftment beyond overcoming immune barriers by stimulating stem cell differentiation.
    Hexner EO; Danet-Desnoyers GA; Zhang Y; Frank DM; Riley JL; Levine BL; Porter DL; June CH; Emerson SG
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1135-44. PubMed ID: 17889349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mesenchymal stem cells from human cord blood promote engraftment of human umbilical cord blood-derived CD34+ cells in NOD/SCID mice].
    Zhou DH; Huang SL; Huang K; Wu YF; Bao R; Wei J; Zhang XC; Li Y
    Zhonghua Xue Ye Xue Za Zhi; 2005 Dec; 26(12):732-5. PubMed ID: 16620577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engraftment capacity of umbilical cord blood cells processed by either whole blood preparation or filtration.
    Eichler H; Kern S; Beck C; Zieger W; Klüter H
    Stem Cells; 2003; 21(2):208-16. PubMed ID: 12634417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinically relevant expansion of hematopoietic stem cells with conserved function in a single-use, closed-system bioprocess.
    Madlambayan GJ; Rogers I; Purpura KA; Ito C; Yu M; Kirouac D; Casper RF; Zandstra PW
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1020-30. PubMed ID: 17084368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similar myeloid recovery despite superior overall engraftment in NOD/SCID mice after transplantation of human CD34(+) cells from umbilical cord blood as compared to adult sources.
    Noort WA; Wilpshaar J; Hertogh CD; Rad M; Lurvink EG; van Luxemburg-Heijs SA; Zwinderman K; Verwey RA; Willemze R; Falkenburg JH
    Bone Marrow Transplant; 2001 Jul; 28(2):163-71. PubMed ID: 11509934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on the mechanism of enhancing homing efficiency of human hematopoietic stem/progenitor cells into bone marrow after manipulation with tumor necrosis factor alpha in xenotransplanted BALB/c mouse model].
    Dai HS; Gao JT; Zhang TW; Yang Z; Che YZ; Zheng YZ
    Zhonghua Xue Ye Xue Za Zhi; 2009 Feb; 30(2):97-102. PubMed ID: 19563019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved engraftment of human cord blood stem cells in NOD/LtSz-scid/scid mice after irradiation or multiple-day injections into unirradiated recipients.
    Lowry PA; Shultz LD; Greiner DL; Hesselton RM; Kittler EL; Tiarks CY; Rao SS; Reilly J; Leif JH; Ramshaw H; Stewart FM; Quesenberry PJ
    Biol Blood Marrow Transplant; 1996 Feb; 2(1):15-23. PubMed ID: 9078350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of engraftment potential of human cord blood stem-progenitor cells as a function of donor cell dosage and gestational age in the NOD/SCID mouse model.
    Ural SH; Sammel MD; Blakemore KJ
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):990-4. PubMed ID: 16157099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engraftment potential into NOD/SCID mice of CD34+ cells derived from human fetal liver as compared to fetal bone marrow.
    Wilpshaar J; Noort WA; Kanhai HH; Willemze R; Falkenburg JH
    Haematologica; 2001 Oct; 86(10):1021-8. PubMed ID: 11602407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intra-bone marrow infusion of human cord blood hematopoietic stem/progenitor cells improves hematopoietic reconstitution in NOD-SCID mice].
    Meng ZT; Gao JT; Lu SH; Yan X; Li YH; Yang Z; Zheng YZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):1010-5. PubMed ID: 19698249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An assay for human hematopoietic stem cells based on transplantation into nonobese diabetic recombination activating gene-null perforin-null mice.
    Minamiguchi H; Wingard JR; Laver JH; Mainali ES; Shultz LD; Ogawa M
    Biol Blood Marrow Transplant; 2005 Jul; 11(7):487-94. PubMed ID: 15983548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced engraftment of human cells in RAG2/gammac double-knockout mice after treatment with CL2MDP liposomes.
    Rozemuller H; Knaän-Shanzer S; Hagenbeek A; van Bloois L; Storm G; Martens AC
    Exp Hematol; 2004 Nov; 32(11):1118-25. PubMed ID: 15539091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-3 promotes proliferation and differentiation of human hematopoietic stem cells but reduces their repopulation potential in NOD/SCID mice.
    Nitsche A; Junghahn I; Thulke S; Aumann J; Radonić A; Fichtner I; Siegert W
    Stem Cells; 2003; 21(2):236-44. PubMed ID: 12634420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.